Mechanisms by which metals promote events connected to neurodegenerative diseases

Brain Research Bulletin

Volumn 55, Issue 2, 2001, Pages 125-132

  Campbell, Arezoo ^a   Smith, Mark A ^b   Sayre, Lawrence M ^b   Bondy, Stephen C ^a   Perry, George ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

amyloid; Aluminum; Copper; Iron; Prion related protein (PrP)

Indexed keywords

ALUMINUM DERIVATIVE; AMYLOID BETA PROTEIN; ANTIOXIDANT; COPPER ION; ENZYME; METAL ION; PRION PROTEIN; PROTEIN;

AGED; BRAIN DISEASE; CHRONIC DISEASE; COLLOID; CONFERENCE PAPER; DEGENERATIVE DISEASE; DISEASE COURSE; ENVIRONMENTAL FACTOR; HOMEOSTASIS; HUMAN; INFLAMMATION; METAL BINDING; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; REGULATORY MECHANISM;

AGING; ANIMALS; ENCEPHALITIS; HUMANS; METALS; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; REACTIVE OXYGEN SPECIES; TRACE ELEMENTS;

EID: 0035872474     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(01)00455-5     Document Type: Conference Paper

References (113)

1. Amyloid β peptide stimulates nitric oxide production in astrocytes through an NF-κB-dependent mechanism
2. Protein oxidative damage in a transgenic mouse model of familial amytrophic lateral sclerosis
3. Dramatic aggregation of Alzheimer A_ by Cu(II) is induced by conditions representing physiological acidosis
4. The dialysis encephalopathy syndrome. Possible aluminum intoxication
5. Function and activation of NF-κB in the immune system
6. Clinical conditions altering copper metabolism in humans
7. Evidence for an early inflammatory response in the central nervous system of mice with scrapie
8. - forming NADPH oxidase in microglia, monocytes, and neutrophils
9. Content of brain aluminum is not elevated in Alzheimer disease
10. The promotion of iron-induced generation of reactive oxygen species in nerve tissue by aluminum
11. Mechanisms underlying the aluminum-induced potentiation of the pro-oxidant properties of transition metals
12. Aluminum but not iron treatment induces pro-oxidant events in the rat brain
13. Elevated "hydroxyl radical" generation in vivo in an animal model of amyotrophic lateral sclerosis
14. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment
15. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity
16. Prion protein expression and superoxide dismutase activity
17. Microglial expression of the prion protein
18. Effects of copper on survival of prion protein knockout neurons and glia
19. Normal prion protein has an activity like that of superoxide dismutase
20. Prion protein peptide neurotoxicity can be mediated by astrocytes
21. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1
22. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro
23. Regulation of the release of interleukin-6 from human astrocytoma cells
24. Aluminum induced oxidative events in cell lines: Glioma are more responsive than neuroblastoma
25. Prion protein glycosylation is sensitive to redox changes
26. Interleukin-1β activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: Implications for Alzheimer's disease
27. Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin?
28. Abnormal iron deposition associated with lipid peroxidation in transgenic mice expressing interleukin-6 in the brain
29. Effects of postnatal aluminum exposure on biological parameters in the plasma
30. Mitochondrial dysfunction induced by oxidative stress in the brains of hamsters infected with the 263 K scrapie agent
31. Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid β-peptide by microglial cells
32. Aluminum toxicity and metal speciation: Established data and open questions
33. Chaperone-facilitated copper binding is a property common to several classes of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants
34. Inflammatory nodular reactions after hepatitis B vaccination due to aluminum sensitization
35. Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration
36. Complement activation by cross-linked truncated and chimeric full-length β-amyloid
37. Evidence that the β-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of Aβ by zinc
38. Perivascular astrocytes within Alzheimer's disease plaques
39. Glial reaction in the hippocampal formation is highly concentrated with aging in human brain
40. Oxidative stress and overexpression of manganese superoxide dismutase in patients with Alzheimer's disease
41. Aluminum in total parenteral nutrition solutions produces portal inflammation in rats
42. Cytokines as mediators of chronic inflammatory disease
43. Tumor necrosis factor-alpha increases lactoferrin transcytosis through the blood-brain barrier
44. Induction of production of nitric oxide in microglial cells by insoluble form of aluminium
45. Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: Molecular mechanisms of neuronal death and protection
46. Amyloid β peptide potentiates cytokine secretion by interleukin-1β-activated human astrocytoma cells
47. Reactions of hydrogen peroxide with familial amyotrophic lateral sclerosis mutant human copper-zinc superoxide dismutases studies by pulse radiolysis
48. Glial-neuronal interactions in Alzheimer's disease: The potential role of a 'cytokine cycle' in disease progression
49. Aceruloplasminemia: An inherited neurodegenerative disease with impairment of iron homeostasis
50. Subunit asymmetry in the three-dimensional structure of a human CuZnSOD mutant found in familial amyotrophic lateral sclerosis
51. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction
52. Cu(II) potentiation of Alzheimer's Aβ neurotoxicity
53. Glial-derived proteins activate cultured astrocytes and enhance beta amyloid-induced glial activation
54. Effect of aluminum on regional brain antioxidant defense status in Wistar rats
55. Essential trace element alterations in amyotrophic lateral sclerosis
56. Copper-dependent inflammation and nuclear factor-κB activation by particulate air pollution
57. Post-ischemic changes in the expression of Alzheimer's APP isoforms in rat cerebral cortex
58. Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice
59. Effects of interferon-gamma and lipopolysaccharide on macrophage iron metabolism are mediated by nitric oxide-induced degradation of iron regulatory protein 2
60. Copper biochemistry and molecular biology
61. 2
62. Increased regional brain concentration of ceruloplasmin in neurodegenerative disorders
63. Copper, iron and zinc in Alzheimer's disease senile plaques
64. Strong nuclear factor -κB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex
65. Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide
66. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease
67. Amyloid precursor protein protect neurons of transgenic mice against acute and chronic excitation injuries in vivo
68. Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories
69. Activation of microglial cells by β-amyloid protein and interferon-γ
70. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase
71. Memory-enhancing effects of secreted forms of the β-amyloid precursor protein in normal and amnestic mice
72. Copper/zinc ratio and systemic oxidant load: Effect of aging and aging-related degenerative diseases
73. The amyloid precursor protein of Alzheimer's disease in the reduction of copper (II) to copper (I)
74. Copper-binding amyloid precursor protein undergoes a site-specific fragmentation in the reduction of hydrogen peroxide
75. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease
76. Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome
77. Neuronal oxidative stress precedes amyloid-β deposition in Down syndrome
78. Early glycoxidation damage in brains from Down's syndrome
79. Iron-mediated generation of the neurotoxin 6-hydroxydopamine quinone by reaction of fatty acid hydroperoxides with dopamine: A possible contributory mechanism for neuronal degeneration in Parkinson's disease
80. Encephalopathy after bladder irrigation with alum: Case report and literature review
81. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
82. Prion protein fragment 106-126 differentially induces heme oxygenase-1 mRNA in cultured neurons and astroglial cells
83. Complement activation by β-amyloid in Alzheimer's disease
84. Inflammatory mediators in Alzheimer's disease
85. Translation of the Alzheimer's amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5′-untranslated region sequences
86. Aluminum intoxication in undialysed adults with chronic renal failure
87. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease
88. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: A central role for bound transition metals
89. Beta (1-40) amyloid peptide injection into the nucleus basalis of rats induces microglia reaction and enhances cortical gamma-aminobutyric acid release in vivo
90. Astrocytes, brain aging, and neurodegeneration
91. Astroctye mitochondria: A substrate for iron deposition in the aging rat substantia nigra
92. Amyloid peptides are toxic via a common oxidative mechanism
93. Activation of microglial cells by PrP and β-amyloid fragments raises intracellular calcium through L-type voltage sensitive calcium channels
94. 2
95. The role of the amyloid protein precursor (APP) in Alzheimer's disease. Does the normal function of APP explain the topography of neurodegeneration?
96. Advanced Maillard reaction end products are associated with Alzheimer disease pathology
97. Oxidative damage in Alzheimer's
98. Widespread peroxynitrite-mediated damage in Alzheimer's disease
99. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
100. Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress
101. Abnormal localization of iron regulatory protein (IRP) in Alzheimer disease
102. Reactive microgliosis
103. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor
104. Overexpression of human copper, zinc-superoxide dismutase (SOD1) prevents postischemic injury
105. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease
106. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis
107. Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice
108. Brain aluminum in Alzheimer's disease using an improved GFAAS method
109. The stabilization of ferrous iron by a toxic β-amyloid fragment and by an aluminum salt
110. An aluminum-induced increase in GFAP is attenuated by some chelators
111. Activated microglia cause iron-dependent lipid peroxidation in the presence of ferritin
112. Free radical formation in autopsy samples of Alzheimer's and control cortex